Wayne Saville

572 total citations
8 papers, 446 citations indexed

About

Wayne Saville is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wayne Saville has authored 8 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Wayne Saville's work include Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Wayne Saville is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Wayne Saville collaborates with scholars based in United States, Switzerland and Canada. Wayne Saville's co-authors include Mark R. Green, Jane C. Weeks, James E. Herndon, Michael C. Perry, Jimmie C. Holland, Antonius A. Miller, Dorothy Watson, Marcy A. List, P Chahinian and Stephen L. Graziano and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biology of Blood and Marrow Transplantation.

In The Last Decade

Wayne Saville

8 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wayne Saville United States 4 347 323 57 54 39 8 446
M. Lomas Spain 7 419 1.2× 364 1.1× 94 1.6× 52 1.0× 39 1.0× 23 518
Nathalie Syz France 5 283 0.8× 292 0.9× 62 1.1× 57 1.1× 17 0.4× 5 490
N. Vardakis Greece 11 348 1.0× 201 0.6× 68 1.2× 113 2.1× 37 0.9× 35 436
T-E. Ciuleanu Romania 11 266 0.8× 240 0.7× 57 1.0× 46 0.9× 18 0.5× 47 345
Alper Can Türkiye 12 228 0.7× 146 0.5× 37 0.6× 60 1.1× 39 1.0× 29 338
Athina Agelidou Greece 14 629 1.8× 580 1.8× 146 2.6× 78 1.4× 70 1.8× 31 756
Alexander Golf Germany 6 332 1.0× 199 0.6× 29 0.5× 65 1.2× 50 1.3× 13 378
A. Chemaissani Germany 9 464 1.3× 508 1.6× 124 2.2× 37 0.7× 18 0.5× 13 650
Jane Bromund United States 9 447 1.3× 467 1.4× 127 2.2× 85 1.6× 21 0.5× 17 609
F. Bustin Belgium 6 336 1.0× 354 1.1× 122 2.1× 47 0.9× 20 0.5× 11 459

Countries citing papers authored by Wayne Saville

Since Specialization
Citations

This map shows the geographic impact of Wayne Saville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Saville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Saville more than expected).

Fields of papers citing papers by Wayne Saville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Saville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Saville. The network helps show where Wayne Saville may publish in the future.

Co-authorship network of co-authors of Wayne Saville

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Saville. A scholar is included among the top collaborators of Wayne Saville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Saville. Wayne Saville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mehren, Margaret von, Carolyn D. Britten, Wayne Saville, et al.. (2014). A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors. Investigational New Drugs. 32(3). 518–525. 16 indexed citations
2.
3.
Shah, Jatin J., Wayne Saville, John Lister, et al.. (2006). Safety and efficacy of retreating follicular non-Hodgkin’s lymphoma (NHL) with 90Y ibritumomab tiuxetan. Journal of Clinical Oncology. 24(18_suppl). 17528–17528. 2 indexed citations
4.
Jacobs, Samuel A., Anthony M. Harrison, Steven H. Swerdlow, et al.. (2004). Cellular Localization Pattern of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in a Patient with Low-Grade Non-Hodgkin’s Lymphoma (NHL).. Blood. 104(11). 4569–4569. 1 indexed citations
5.
Lilenbaum, Rogério, James E. Herndon, Marcy A. List, et al.. (2004). Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730). Journal of Clinical Oncology. 23(1). 190–196. 352 indexed citations
6.
7.
Lima, Caio Max S. Rocha, Diane Savarese, Howard W. Bruckner, et al.. (2002). Irinotecan Plus Gemcitabine Induces Both Radiographic and CA 19-9 Tumor Marker Responses in Patients With Previously Untreated Advanced Pancreatic Cancer. Journal of Clinical Oncology. 20(5). 1182–1191. 64 indexed citations
8.
Friedman‐Kien, Alvin E., B. J. Dezube, Lawrence D. Kaplan, et al.. (1998). Oral 9-cis-Retinoic Acid is active in AIDS related Kaposi's sarcoma: AIDS Associated Malignancy Consortium Study 002. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A24–A24. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Lomas Breakdown of academic impact, for papers by Nathalie Syz Breakdown of academic impact, for papers by N. Vardakis Breakdown of academic impact, for papers by T-E. Ciuleanu Breakdown of academic impact, for papers by Alper Can Breakdown of academic impact, for papers by Athina Agelidou Breakdown of academic impact, for papers by Alexander Golf Breakdown of academic impact, for papers by A. Chemaissani Breakdown of academic impact, for papers by Jane Bromund Breakdown of academic impact, for papers by F. Bustin
Rankless by CCL
2026